Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Blueprint Medicines (BPMC)
NASDAQ:BPMC
Holding BPMC?
Track your performance easily
Blueprint Medicines (BPMC) Ownership Overview
1.56% Insiders
43.82% Mutual Funds
5.48% Other Institutional Investors
17.91% ETFs
31.22% Public Companies and
Individual Investors
The ownership structure of Blueprint Medicines (BPMC) stock is a mix of institutional, retail, and individual investors. Approximately 67.22% of the company’s stock is owned by Institutional Investors, 1.56% is owned by Insiders, and 31.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 04, 2024 | Fouad Namouni President, R & D | xxxxxxxxxxxxx | $324500 |
| Aug 07, 2024 | Philina Lee Cco | xxxxxxxxxxxxx | $3905872 |
| Jun 07, 2024 | xxxxxxxxxxxxx | $420520 | |
| Jun 05, 2024 | xxxxxxxxxxxxx | $259263 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $138928 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $318597 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $36231863 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $38612723 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,973,133 | Institution | 9.40% | 596,536,793 | |
| 5,410,941 | Institution | 8.52% | 540,390,678 | |
| 2,998,483 | Institution | 4.72% | 299,458,497 | |
| 2,071,588 | Institution | 3.26% | 206,889,494 | |
| 1,794,139 | Institution | 2.82% | 179,180,662 | |
| 1,511,267 | Institution | 2.38% | 150,930,235 | |
| 1,489,652 | Institution | 2.34% | 148,771,545 | |
| 1,407,906 | Institution | 2.22% | 140,607,572 | |
| 913,796 | Institution | 1.44% | 91,260,807 | |
| 880,147 | Institution | 1.39% | 87,900,281 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,410,941 | Institution | 8.52% | 540,390,678 | |
| 2,071,588 | Institution | 3.26% | 206,889,494 | |
| 1,794,139 | Institution | 2.82% | 179,180,662 | |
| 1,511,267 | Institution | 2.38% | 150,930,235 | |
| 1,489,652 | Institution | 2.34% | 148,771,545 | |
| 913,796 | Institution | 1.44% | 91,260,807 | |
| 803,730 | Institution | 1.27% | 80,268,515 | |
| 775,117 | Institution | 1.22% | 77,410,935 | |
| 701,038 | Institution | 1.10% | 70,012,665 | |
| 687,295 | Institution | 1.08% | 68,640,152 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,997,389 | Institution | 3.14% | 184,758,483 | |
| 1,723,713 | Institution | 2.71% | 172,147,217 | |
| 1,585,695 | Institution | 2.50% | 146,676,788 | |
| 1,315,265 | Institution | 2.07% | 132,618,170 | |
| 950,313 | Institution | 1.50% | 87,903,953 | |
| 874,422 | Institution | 1.38% | 80,884,035 | |
| 565,377 | Institution | 0.89% | 56,464,201 | |
| 436,704 | Institution | 0.69% | 43,613,628 | |
| 306,149 | Institution | 0.48% | 30,869,004 | |
| 288,329 | Institution | 0.45% | 26,670,433 |
FAQ
Who Owns Blueprint Medicines (BPMC)?
According to the latest TipRanks data, approximately 5.48% of the company's stock is held by institutional investors, 1.56% is held by insiders, and 31.22% is held by retail investors.
What percentage of Blueprint Medicines (BPMC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.48% of Blueprint Medicines (BPMC) stock is held by institutional investors.
What percentage of Blueprint Medicines (BPMC) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.22% of Blueprint Medicines (BPMC) stock is held by retail investors.
Who owns the most shares of Blueprint Medicines (BPMC)?
Vanguard owns the most shares of Blueprint Medicines (BPMC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.